These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8590869)

  • 1. [Theoretical conformational NMR-analysis of RP342 peptide, affiliated with the immunogenic fragment of HIV-1 gp120 protein].
    Andrianov AM
    Dokl Akad Nauk; 1995 Oct; 344(4):546-8. PubMed ID: 8590869
    [No Abstract]   [Full Text] [Related]  

  • 2. [Theoretical conformational NMR analysis of peptide RP342 of the immunogenic fragment of HIV-1 protein gp120].
    Andrianov AM; Akhrem AA
    Dokl Akad Nauk; 1996 Nov; 351(3):401-3. PubMed ID: 9011297
    [No Abstract]   [Full Text] [Related]  

  • 3. [Theoretical study of peptide spatial structure--fragments of the base antigenic determinant of HIV-1 gp120 protein. I. Peptides rp142 and rp342].
    Andrianov AM
    Mol Biol (Mosk); 1997; 31(5):861-71. PubMed ID: 9454072
    [No Abstract]   [Full Text] [Related]  

  • 4. [Theoretical study of peptide spatial structure--fragments of the base antigenic determinant of HIV-1 gp120 protein. II. Hexapeptide Gly-Pro- Gly-Arg-Ala-Phe].
    Andrianov AM
    Mol Biol (Mosk); 1997; 31(5):872-9. PubMed ID: 9454073
    [No Abstract]   [Full Text] [Related]  

  • 5. [Spatial structure of the rp142 peptide containing the immunodominant epitope of the HIV-1 gp120 protein. A theoretical study].
    Andrianov AM; Akhrem AA
    Biofizika; 1999; 44(1):10-7. PubMed ID: 10330579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
    Vu HM; de Lorimier R; Moody MA; Haynes BF; Spicer LD
    Biochemistry; 1996 Apr; 35(16):5158-65. PubMed ID: 8611499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The principal neutralizing determinant of HIV-1 located in V3 of gp120 forms a 12-residue loop by internal hydrophobic interactions.
    Zvi A; Kustanovich I; Hayek Y; Matsushita S; Anglister J
    FEBS Lett; 1995 Jul; 368(2):267-70. PubMed ID: 7543061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A; Feigelson DJ; Hayek Y; Anglister J
    Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modeling of the 3D structure of the HIV-Haiti immunodominant epitope].
    Biofizika; 2006; 51(1):81-91. PubMed ID: 16521557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A spatial structure model of the basic antigenic determinant of the human immunodeficiency virus type 1 gp120 protein].
    Andrianov AM; Akhrem AA
    Dokl Akad Nauk; 1995 Jun; 342(4):543-5. PubMed ID: 7580959
    [No Abstract]   [Full Text] [Related]  

  • 11. Local structural properties of the V3 loop of Thailand HIV-1 isolate.
    Andrianov AM
    J Biomol Struct Dyn; 2002 Jun; 19(6):973-89. PubMed ID: 12023800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structure and conformational properties of the HIV Thailand gp120 immunodominant epitope].
    Andrianov AM
    Mol Biol (Mosk); 2002; 36(4):715-24. PubMed ID: 12173478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conformation of the HIV-1 gp120 V3 loop. Structure functional analysis of the HIV-Haiti viral strain].
    Andrianov AM
    Tsitologiia; 2006; 48(11):948-57. PubMed ID: 17233480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and polymorphism of the principal neutralization site of Thailand HIV-1 isolate.
    Andrianov AM; Sokalov YA
    J Biomol Struct Dyn; 2003 Feb; 20(4):603-13. PubMed ID: 12529159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometric characterization of a discontinuous epitope of the HIV envelope protein HIV-gp120 recognized by the human monoclonal antibody 1331A.
    Hochleitner EO; Gorny MK; Zolla-Pazner S; Tomer KB
    J Immunol; 2000 Apr; 164(8):4156-61. PubMed ID: 10754311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational study of fragments of envelope proteins (gp120: 254-274 and gp41: 519-541) of HIV-1 by NMR and MD simulations.
    Kanyalkar M; Srivastava S; Saran A; Coutinho E
    J Pept Sci; 2004 Jun; 10(6):363-80. PubMed ID: 15214441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-state NMR evidence for an antibody-dependent conformation of the V3 loop of HIV-1 gp120.
    Weliky DP; Bennett AE; Zvi A; Anglister J; Steinbach PJ; Tycko R
    Nat Struct Biol; 1999 Feb; 6(2):141-5. PubMed ID: 10048925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135.
    Huang X; Barchi JJ; Lung FD; Roller PP; Nara PL; Muschik J; Garrity RR
    Biochemistry; 1997 Sep; 36(36):10846-56. PubMed ID: 9312273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global and local structural properties of the principal neutralizing determinant of the HIV-1 envelope protein gp120.
    Andrianov AM
    J Biomol Struct Dyn; 1999 Feb; 16(4):931-53. PubMed ID: 10217460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.